Video Experimental Relacionado

Updated: Apr 6, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.3K

Primer uso clínico de un corazón artificial bioprótesis total: informe de dos casos

Alain Carpentier1, Christian Latrémouille1, Bernard Cholley2

  • 1Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.

Lancet (London, England)
|August 2, 2015
PubMed
Resumen

En este estudio se evaluó el CARMAT Total Artificial Heart (C-TAH) en dos pacientes con insuficiencia cardíaca terminal. Si bien demostró la viabilidad y el potencial para reducir la trombosis, las fallas del dispositivo condujeron a la mortalidad del paciente, destacando los desafíos en el desarrollo total del corazón artificial.

Más Videos Relacionados

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.4K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.1K

Videos de Conceptos Relacionados

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
585